Over recent years, significant progress has been made in characterisation of the underlying
pathogenic mechanisms in psoriasis, a common cutaneous disease that is associated with …

Psoriasis is considered an immune chronic disease in which T cells are accepted as
important. Nowadays, it is believed that psoriasis is most likely a T helper (Th) 1/Th17 …

Certain therapeutic microbes, including Bifidobacteria infantis (B. infantis) 35624 exert
beneficial immunoregulatory effects by mimicking commensal-immune interactions; …

Recent progress in the understanding of psoriasis has shown that the regulation of local and
systemic cytokines plays an important role in its pathogenesis. The most often used …

More than 10 disease-modifying therapies (DMT) are approved by the European Medicines
Agency (EMA) and the US Food and Drug Administration (FDA) for the treatment of multiple …

Psoriasis is a chronic, systemic, hyper-proliferative immune-mediated inflammatory skin
disease. The results of epidemiological investigations have shown that psoriasis affects …

Background Several cross‐sectional studies have shown that different cytokines and growth
factors are enhanced in psoriasis. Objectives We aimed to understand the role/relation of …

The past decades have yielded major therapeutic advances in many autoimmune conditions–
such as multiple sclerosis (MS)–and thus ushered in a new era of more targeted and …

Psoriasis is a chronic inflammatory skin disease, often associated with overweight/obesity.
The adipose tissue is a complex organ that secretes several adipokines, involved in the …

Psoriasis is a common, chronic, inflammatory, immune-mediated skin disease affecting
about 2% of the world's population. According to current knowledge, psoriasis is a complex …